DiaMedica Therapeutics, Inc. (DMAC)

8.30 -0.20 (-2.35%) USD  |  NASDAQ  |  Feb 20, 13:01
More

DiaMedica Therapeutics Consensus Recommendation

Consensus Recommendation Chart

View Consensus Recommendation for DMAC.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Consensus Recommendation Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Consensus Recommendation Range, Past 5 Years

View Consensus Recommendation Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Consensus Recommendation Benchmarks

View Consensus Recommendation Benchmarks
Start Trial
XOMA Royalty Corp. Upgrade
Avantor, Inc. Upgrade
ACADIA Pharmaceuticals, Inc. Upgrade
Alnylam Pharmaceuticals, Inc. Upgrade
Savara, Inc. Upgrade